SCHEMBL1750818

SCHEMBL1750818

Fc1ccc(-c2cnn(C(c3ccccc3)(c3ccccc3)c3ccccc3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 2/20 0.38
ALDH1A3 P47895 1/20 0.38
MLNR O43193 1/20 0.37
NR1I2 O75469 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
TBXA2R P21731 1/20 0.37
CCKBR P32239 1/20 0.37
OPRK1 P41145 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KCNH2 Q12809 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
GRM5 P41594 2/20 0.36
NPSR1 Q6W5P4 3/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
FLT3 P36888 2/20 0.35
GPR55 Q9Y2T6 2/20 0.35
KDR P35968 1/20 0.35
PGR P06401 1/20 0.34
KCNN4 O15554 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29771432 0.92 L3MBTL1 (0.41) L3MBTL1KDRKCNN4HPGDMAPK1
SCHEMBL70574 0.88 L3MBTL1 (0.44) L3MBTL1KDRKCNN4ALDH1A1HPGD
SCHEMBL9058051 0.84 SLC2A1 (0.39) ALDH1A3LMNAL3MBTL1FLT3KDR
SCHEMBL22614609 0.81 SCN5A (0.44) KCNH2KDM4EALDH1A1GAAMAPT
SCHEMBL8814676 0.80 L3MBTL1 (0.40) KCNH2L3MBTL1KDRKCNN4ALDH1A1
SCHEMBL3847041 0.79 MEN1 (0.46) LMNAKDM4EALDH1A1HPGDMEN1
SCHEMBL3846776 0.79 ATM (0.41) NR3C1PGRALDH1A1HPGDMAPK1
SCHEMBL8320062 0.78 AXL (0.54)
SCHEMBL27869499 0.76 L3MBTL1 (0.52) LMNAL3MBTL1GPR55KDRKDM4E
SCHEMBL29771434 0.75 CREBBP (0.35) GRM5LMNAKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968579-B2 Antifungal triazole derivatives DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2011-06-28 US disclosed
CN-101365692-A Novel antifungal triazole derivatives DAE WOONG PHARMA (KR) 2009-02-11 CN disclosed
US-20080287440-A1 Novel Antifungal Triazole Derivatives DAEWOONG PHARMACEUTIDCAL CO., LTD. (KR) 2008-11-20 US disclosed
EP-1951705-A1 NOVEL ANTIFUNGAL TRIAZOLE DERIVATIVES DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2008-08-06 EP disclosed
WO-2007052943-A1 NOVEL ANTIFUNGAL TRIAZOLE DERIVATIVES DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2007-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287440-A1 Novel Antifungal Triazole Derivatives CYP51A1, ERG28, CYP3A43 NR3C1 1012/4885ALDH1A3 2611/4885MLNR 2948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.